Inventronics (Hangzhou)(SZ:300582) Xin Lang Cai Jing·2025-11-12 10:29Core Viewpoint - The company has approved several resolutions during its board meeting, including capital investments and acquisitions in the biotechnology sector [1] Group 1: Investment Activities - The company’s wholly-owned subsidiary, Yingfei Investment, will invest 13.44 million yuan to subscribe for an additional registered capital of 1.344 million yuan in Qinghai Chunwan Huakai Biotechnology Co., Ltd [1] - Yingfei Investment will acquire 100% of the registered capital of Bincao Biotechnology for 15.6 million yuan, resulting in a direct and indirect ownership of 5.66% in the target company [1] - The controlling shareholder and chairman, Guichaohua, will assume a contingent repurchase obligation for the investment [1] Group 2: Capital Increase - The company has agreed to increase the capital of Yingfei Investment by 25 million yuan, raising its registered capital to 52 million yuan [1] Group 3: Future Meetings - The company plans to hold its second extraordinary general meeting of shareholders on November 28, 2025 [1]